Kishor M. Wasan
Direktor/Vorstandsmitglied bei The Pharmacy Association of Saskatchewan
Profil
Kishor M.
Wasan is currently a Director at The Pharmacy Association of Saskatchewan.
Previously, he worked as a Research Director at iCo Therapeutics, Inc.
Aktive Positionen von Kishor M. Wasan
Unternehmen | Position | Beginn |
---|---|---|
The Pharmacy Association of Saskatchewan
The Pharmacy Association of Saskatchewan Miscellaneous Commercial ServicesCommercial Services The Pharmacy Association of Saskatchewan represents pharmacists and pharmacies in Saskatchewan. It provides member service programs and benefits including liability insurance and pharmacy practice support. The firm also researches and develops pharmacist services programming, remuneration schedules and practice support material. The company is headquartered in Regina, Canada. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Kishor M. Wasan
Unternehmen | Position | Ende |
---|---|---|
SATELLOS BIOSCIENCE INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
The Pharmacy Association of Saskatchewan
The Pharmacy Association of Saskatchewan Miscellaneous Commercial ServicesCommercial Services The Pharmacy Association of Saskatchewan represents pharmacists and pharmacies in Saskatchewan. It provides member service programs and benefits including liability insurance and pharmacy practice support. The firm also researches and develops pharmacist services programming, remuneration schedules and practice support material. The company is headquartered in Regina, Canada. | Commercial Services |
iCo Therapeutics, Inc.
iCo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology iCo Therapeutics, Inc. is a canadian biotechnology company. It engages in the business of identification, development and commercialization of drug candidates to treat ocular and infectious diseases. Its products include iCo-008 and oral AmpB delivery system. The company was founded by Andrew J. Rae, John G. Clement and William John Meekison on February 15, 2005 and is headquartered in Vancouver, CA. | Health Technology |